Direct-acting antiviral (NS5B inhibitor)
Sofosbuvir
- Brands
- 1
- Forms
- Tablet 400 mg
- Used in
- 1 protocols
- Status
- Not verified
Brand list not yet checked by a pharmacist. Confirm in the DRAP registered-drugs database.
Indications
- Used for
- Chronic hepatitis C (genotype 3 predominates in Pakistan), with daclatasvir.
- Pakistan note
- Several DRAP-registered generics are widely available and also supplied free through provincial hepatitis control programmes.
Cautions
- Interaction with amiodarone (serious bradycardia)
- Check HBV status first; reactivation risk
Brands in Pakistan
SovaldiGilead